A Multicentre, Randomized, Double-blind, Parallel-group Study To Compare The Efficacy Of Golimumab In Combination With Methotrexate (MTX) Versus MTX Monotherapy, In Improving Dactylitis And Enthesitis, In MTX Naïve Psoriatic Arthritis Patients
Latest Information Update: 12 May 2022
At a glance
- Drugs Golimumab (Primary) ; Methotrexate
- Indications Psoriatic arthritis
- Focus Proof of concept; Therapeutic Use
- Acronyms GO-DACT
- 01 Apr 2020 Results published in the Annals of the Rheumatic Diseases
- 15 Jun 2019 Due to favorable results on a planned interim analysis recruitment was halted after 44 patients were centrally randomized according to results presented at the 20th Annual Congress of the European League Against Rheumatism
- 15 Jun 2019 Primary endpoint (Dactylitis Severity Score (DSS)) has been met as per results presented at the 20th Annual Congress of the European League Against Rheumatism